CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Total revenues	$ 0	$ 24,687
Total costs of revenues	0	12,196
Gross profit	0	12,491
Operating expenses:
Sales and marketing	91	2,527
Research and development	21	1,043
General and administrative	3,992	10,553
Depreciation and amortization	170	525
Stock-based compensation	920	981
Goodwill, intangible asset, and other long-lived asset impairments	0	495
Acquisition, integration, and transformation costs	176	3,400
Total operating expenses	5,370	19,524
Loss from operations	(5,370)	(7,033)
Other expense:
Interest expense	(5,529)	(6,758)
Other income, net, including interest income	3,539	58
Total other expense	(1,990)	(6,700)
Loss before income tax expense	(7,360)	(13,733)
Income tax expense	(4,519)	0
Net loss from continuing operations	(11,879)	(13,733)
Net income from discontinued operations, net of tax	37,300	6,098
Net income (loss)	25,421	(7,635)
Less: net income attributable to noncontrolling interests	0	448
Net income (loss) attributable to UpHealth, Inc.	$ 25,421	$ (8,083)
Net income (loss) per share - basic and diluted
Continuing operations, basic (in dollars per share)	$ (0.64)	$ (0.87)
Continuing operations, diluted (in dollars per share)	(0.64)	(0.87)
Discontinued operation, net of tax, basic (in dollars per share)	1.99	0.39
Discontinued operations, net of tax, diluted (in dollars per share)	1.99	0.39
Attributable to UpHealth, Inc., basic (in dollars per share)	1.36	(0.51)
Attributable to UpHealth, Inc., diluted (in dollars per share)	$ 1.36	$ (0.51)
Weighted average shares outstanding, basic (in shares)	18,699	15,730
Weighted average shares outstanding, diluted (in shares)	18,699	15,730
Services
Total revenues	$ 0	$ 13,613
Total costs of revenues	0	6,518
Licenses and subscriptions
Total revenues	0	1,936
Total costs of revenues	0	319
Products
Total revenues	0	9,138
Total costs of revenues	$ 0	$ 5,359